BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 32251397)

  • 1. Zebrafish patient avatars in cancer biology and precision cancer therapy.
    Fazio M; Ablain J; Chuan Y; Langenau DM; Zon LI
    Nat Rev Cancer; 2020 May; 20(5):263-273. PubMed ID: 32251397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebrafish Avatars towards Personalized Medicine-A Comparative Review between Avatar Models.
    Costa B; Estrada MF; Mendes RV; Fior R
    Cells; 2020 Jan; 9(2):. PubMed ID: 31991800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zebrafish Xenografts for Drug Discovery and Personalized Medicine.
    Xiao J; Glasgow E; Agarwal S
    Trends Cancer; 2020 Jul; 6(7):569-579. PubMed ID: 32312681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challenges.
    Durinikova E; Buzo K; Arena S
    J Exp Clin Cancer Res; 2021 Jun; 40(1):185. PubMed ID: 34090508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One mouse, one patient paradigm: New avatars of personalized cancer therapy.
    Malaney P; Nicosia SV; Davé V
    Cancer Lett; 2014 Mar; 344(1):1-12. PubMed ID: 24157811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zebrafish Models of Cancer-New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate.
    Hason M; Bartůněk P
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31731811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zebrafish Cancer Avatars: A Translational Platform for Analyzing Tumor Heterogeneity and Predicting Patient Outcomes.
    Al-Hamaly MA; Turner LT; Rivera-Martinez A; Rodriguez A; Blackburn JS
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer cell transplantation in zebrafish: From translational research to personalized medicine].
    Raby L; Völkel P; Le Bourhis X; Angrand PO
    Bull Cancer; 2020 Jan; 107(1):30-40. PubMed ID: 31466696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zebrafish Patient-Derived Avatars from Digestive Cancers for Anti-cancer Therapy Screening.
    Costa B; Estrada MF; Barroso MT; Fior R
    Curr Protoc; 2022 Apr; 2(4):e415. PubMed ID: 35436037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine.
    Di Franco G; Usai A; Funel N; Palmeri M; Montesanti IER; Bianchini M; Gianardi D; Furbetta N; Guadagni S; Vasile E; Falcone A; Pollina LE; Raffa V; Morelli L
    World J Gastroenterol; 2020 Jun; 26(21):2792-2809. PubMed ID: 32550755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zebrafish Avatar to Develop Precision Breast Cancer Therapies.
    Corsinovi D; Usai A; Sarlo M; Giannaccini M; Ori M
    Anticancer Agents Med Chem; 2022; 22(4):748-759. PubMed ID: 33797388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Antitumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft Model.
    Gatzweiler C; Ridinger J; Ayhan S; Najafi S; Peterziel H; Witt O; Oehme I
    Methods Mol Biol; 2023; 2589():75-85. PubMed ID: 36255618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments in zebrafish avatars as radiotherapy sensitivity reporters - towards personalized medicine.
    Costa B; Ferreira S; Póvoa V; Cardoso MJ; Vieira S; Stroom J; Fidalgo P; Rio-Tinto R; Figueiredo N; Parés O; Greco C; Ferreira MG; Fior R
    EBioMedicine; 2020 Jan; 51():102578. PubMed ID: 31862441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.
    Zarzosa P; Navarro N; Giralt I; Molist C; Almazán-Moga A; Vidal I; Soriano A; Segura MF; Hladun R; Villanueva A; Gallego S; Roma J
    Clin Transl Oncol; 2017 Jan; 19(1):44-50. PubMed ID: 27718156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What role could organoids play in the personalization of cancer treatment?
    Francies HE; Garnett MJ
    Pharmacogenomics; 2015; 16(14):1523-6. PubMed ID: 26485224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCR-based zebrafish model for personalised medicine in head and neck cancer.
    Al-Samadi A; Tuomainen K; Kivimäki A; Salem A; Al-Kubati S; Hyytiäinen A; Parikka M; Mesimäki K; Wilkman T; Mäkitie A; Grenman R; Salo T
    J Transl Med; 2019 Jul; 17(1):235. PubMed ID: 31331338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
    Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
    Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
    Gerhards NM; Rottenberg S
    Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts.
    Fior R; Póvoa V; Mendes RV; Carvalho T; Gomes A; Figueiredo N; Ferreira MG
    Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8234-E8243. PubMed ID: 28835536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of zebrafish patient-derived xenograft tumor models in the development of antitumor agents.
    Li X; Li M
    Med Res Rev; 2023 Jan; 43(1):212-236. PubMed ID: 36029178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.